GFM
GMAB icon

GF Fund Management’s Genmab GMAB Stock Holding History

GF Fund Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.2K Buy
1,313
+165
+14% +$4.95K ﹤0.01% 440
2025
Q4 		$35.4K Buy
1,148
+248
+28% +$7.73K ﹤0.01% 444
2025
Q3 		$27.6K Sell
900
-173
-16% -$4.22K ﹤0.01% 452
2025
Q2 		$22.2K Hold
1,073
– – ﹤0.01% 491
2025
Q1 		$21K Buy
1,073
+193
+22% +$4.05K ﹤0.01% 497
2024
Q4 		$18.4K Buy
+880
New +$19.3K ﹤0.01% 479

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

GF Fund Management's GMAB Position: Q1 2026 in Review

GF Fund Management increased its Genmab (GMAB) stake by 14% in Q1 2026, buying an estimated $4.95K and bringing the position to 1,313 shares worth $35.2K. The position accounts for ﹤0.01% of the portfolio, ranked #440.

GF Fund Management first reported a position in GMAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $35.4K in Q4 2025. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • GF Fund Management held 1,313 shares of Genmab worth $35.2K as of Q1 2026.
  • GF Fund Management bought 165 Genmab shares in Q1 2026, an estimated $4.95K.
  • Genmab made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #440 holding.
  • GF Fund Management first reported a position in Genmab in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Genmab position peaked at $35.4K in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.